Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder

NCT05457465 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Cannabidiol

Sponsor

Mclean Hospital